Fulcrum Therapeutics, Inc. (FULC) NASDAQ
3.12
-3.305(-51.48%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.12
-3.305(-51.48%)
Currency In USD
| Market Cap | 716.55M |
| Enterprise Value | 525.46M |
| P/E Ratio | -3.1 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.71 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.58 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.22 |
| Return On Equity | -0.28 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.39M |
| EBITDA | -73.49M |
| Net Income | -74.88M |
| Diluted EPS | -1.18 |
| Total Cash | 333.32M |
| Total Cash/Share | 4.37 |
| Total Debt | 5.87M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 34.33 |
| Book Value Per Share | 4.37 |
| 52-Week Change | -55.24 |
| 52-Week High | 15.74 |
| 52-Week Low | 2.91 |
| Moving Average 50 Days | 7.22 |
| Moving Average 200 Days | 8.8 |
| Average Volume | 910,428 |
| Shares Outstanding | 54.11M |
| % Held by Institutions | 113.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |